The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 25, 2025 for...
26 Sep, 2025 | 10:39am • Source: BSE
PFA Intimation w.r.t Closure of Trading Window
25 Sep, 2025 | 02:01pm • Source: BSE
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 16, 2025 for...
16 Sep, 2025 | 10:41am • Source: BSE
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 10, 2025 for...
10 Sep, 2025 | 03:02pm • Source: BSE
Pls find enclosed Newspaper Advertisement
08 Sep, 2025 | 12:40pm • Source: BSE
Ajanta Pharma Limited has informed the Exchange about Participation in Investor Conference
02 Sep, 2025 | 09:58am • Source: NSE
Please find enclosed intimation w.r.t Participation in Investor Conference.
02 Sep, 2025 | 09:05am • Source: BSE
Pls find enclosed Intimation under Regulation 30 of SEBI LODR Regulations 2015.
20 Aug, 2025 | 09:33pm • Source: BSE
Pls find enclosed Written Transcript of Earnings Call held on 28th July 2025.
31 Jul, 2025 | 11:06am • Source: BSE
Ajanta Pharma Limited has informed the Exchange about Copy of Newspaper Publication
29 Jul, 2025 | 11:58am • Source: NSE
PFA newspaper publication of results for the quarter ended 30.06.2025.
29 Jul, 2025 | 11:37am • Source: BSE
PFA Audio Link of Investor Call.
28 Jul, 2025 | 05:23pm • Source: BSE
PFA ESOP Allotment announcement
28 Jul, 2025 | 03:34pm • Source: BSE
Outcome of the Board Meeting
28 Jul, 2025 | 03:05pm • Source: BSE
PFA Unaudited Financial Results for quarter ended 30.06.2025.
28 Jul, 2025 | 02:59pm • Source: BSE
Pls find enclosed Voting Results pursuant to Regulation 44 of SEBI LODR Regulations and Scrutinizer''s Report
18 Jul, 2025 | 03:23pm • Source: BSE
Please find enclosed Proceedings of AGM pursuant to Regulation 30 of SEBI LODR Regulations, 2015.
17 Jul, 2025 | 03:01pm • Source: BSE
PFA Investor Call Intimation.
16 Jul, 2025 | 04:13pm • Source: BSE
Ajanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2025 ,inter alia, to consider and...
16 Jul, 2025 | 03:56pm • Source: BSE
Ajanta Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
08 Jul, 2025 | 10:18am • Source: NSE